Pfizer enCompass Reimbursement Support and Patient Support
Pfizer
The Pfizer enCompass Co-Pay Assistance Program helps commercially insured patients reduce their out-of-pocket costs for ABRILADA treatment, offering a co-pay as low as $0, with an annual maximum benefit ranging from $4,000 to $14,000. Additionally, eligible patients may receive a Sharps Container and Travel Kit. The program is not available for patients with state or federally funded insurance or cash-paying patients.
- Enrollment cycle
- rolling
Apply
Application goes directly to Pfizer. RxCopays does not receive compensation.
Go to application →Status source
Enrollment required. To enroll your patients in the Pfizer enCompass Co-Pay Assistance Program , contact Pfizer enCompass
Rare-disease support beyond financial help
This grant covers 12 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: